Core Scientific, Inc. Common Stock
Here’s whether Core Scientific, Inc. Common Stock (CORZ) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.58% over 10 days); RSI 50 — healthy momentum range; strong 1-year return of +66.2%; 3-month momentum positive (+9.0%). Concerns: below the 50-day MA (medium-term momentum negative); declining volume on rally — weak conviction (0.77x 30d avg). Currently 25.3% off its 52-week high. Score: +4/7.
CORZ is holding above its long-term 200-day MA ($19.65) but has slipped below the 50-day MA ($25.37), pointing to short-term weakness in an otherwise intact trend. An RSI of 49.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +66.2% compares to +16.5% for SPY (beat the market by 49.7%). The current 25.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.